catalyst calendar
← Catalyst calendar

NKTX biotech catalysts & pipeline

NKARTA INC · Data as of 2026-10-25

Upcoming catalysts

NKX019 — Conference presentation

Nov 8

Title : Preliminary Safety, PK/PD, and Clinical Activity of NKX019, an Allogeneic, CD19-Targeted, CAR NK-Cell Therapy, in Idiopathic Inflammatory Myopathy: Results From an Ongoing, Phase 1/2, Open-Label, Multicenter, Dose-Escalation/Optimization, Basket Study Presentation type: Oral Session : Muscle Biology, Myositis, & Myopathies - Clinical: Novel and Emerging Therapies in Myositis (0902-0907) Date and Time : Sunday, November 8th, 1:15pm-1:30 pm ET Presenting Author : Guillermo J. Valenzuela, MD, FACR, President and Principal Investigator, Integral Rheumatology and Immunology Specialists Abstract # : 0903
Source filing

NKX019 — Conference presentation

Nov 9

Title : Preliminary Safety, PK/PD, and Clinical Activity of NKX019, an Allogeneic, CD19-Targeted, CAR NK-Cell Therapy, in Systemic Sclerosis: Results From an Ongoing, Phase 1/2, Open-Label, Multicenter, Dose-Escalation/Optimization, Basket Study Presentation type: Poster Session: (1172-1182) Systemic Sclerosis & Related Disorders - Treatment Poster B Date and Time : Monday, November 9th, 10:30am-12:30pm ET Presenting Author : Dinesh Khanna, MBBS, MSc, Frederick G.L. Huetwell Professor of Rheumatology and Director, University of Michigan Scleroderma Program Abstract # : 1179
Source filing

NKX019 — Conference presentation

Nov 11

Title : Overall, Immune-Mediated, and Hematologic Safety Outcomes Following Fludarabine/Cyclophosphamide Lymphodepletion and NKX019, an Allogeneic CD19-Targeted CAR NK-Cell Therapy, in B-Cell-Mediated Autoimmune Diseases Presentation type: Oral Session : Miscellaneous Rheumatic & Inflammatory Diseases: Focus on Hematologic Mechanisms and Disease (2935-2940) Date and Time : Wednesday, November 11th, 10:15am -10:30am ET Presenting Author : Guillermo J. Valenzuela, MD, FACR, President and Principal Investigator, Integral Rheumatology and Immunology Specialists Abstract # : 2938
Source filing

Explore the free biotech catalyst calendar